UK markets closed

Renalytix Plc (RENX.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
27.50-0.50 (-1.79%)
At close: 04:17PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 41.31M
Enterprise value 42.63M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.26
Price/book (mrq)19.08
Enterprise value/revenue 17.69
Enterprise value/EBITDA -1.16

Trading information

Stock price history

Beta (5Y monthly) 1.91
52-week change 3-69.44%
S&P500 52-week change 322.38%
52-week high 3150.00
52-week low 310.00
50-day moving average 332.01
200-day moving average 344.54

Share statistics

Avg vol (3-month) 3766.07k
Avg vol (10-day) 3340.33k
Shares outstanding 5147.54M
Implied shares outstanding 6150.22M
Float 857.1M
% held by insiders 131.57%
% held by institutions 121.44%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,175.60%

Management effectiveness

Return on assets (ttm)-88.32%
Return on equity (ttm)-651.40%

Income statement

Revenue (ttm)2.41M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)-40.50%
Gross profit (ttm)N/A
EBITDA -37.79M
Net income avi to common (ttm)-41.85M
Diluted EPS (ttm)-0.36
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.62M
Total cash per share (mrq)0.06
Total debt (mrq)8.48M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.59
Book value per share (mrq)-0.08

Cash flow statement

Operating cash flow (ttm)-36.16M
Levered free cash flow (ttm)-19.77M